Found 11 matching trials
Efficacy and Safety of Rotigotine in the Treatment of Patients With Early Stage of Primary Parkinson's Disease PHASE3 The efficacy and safety of rotigotine in the treatment of patients with ear...
Show More Location
Peking University Third Hospital
Learn More & Join Trial
A Study of LY03003 in Patients With Early-stage Parkinson's Disease PHASE1 This study is to characterize the pharmacokinetics and to evaluate the safe...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Assess Pharmacokinetic Profiles of LY03003 and Neupro PHASE1 Phase 1, single center study to assess pharmacokinetic profiles of rotigoti...
Show More Location
Pharmaron CPC, Inc.
Learn More & Join Trial
Pharmacokinetics and Safety Study of LY03003 in Patients With Early-stage Parkinson's Disease PHASE1 The purpose of this study is to characterize the pharmacokinetics (PK) of L...
Show More Location
Collaborative Neuroscience Network LLC
Learn More & Join Trial
Pharmacokinetic Study of LY03003 in Patients With Parkinson's Disease PHASE1 This is a Phase 1, open-label, parallel-group study to evaluate rotigotine ...
Show More Learn More & Join Trial
A Study to Evaluate the Human Tolerance and Pharmacokinetics of LY03003 PHASE1 This study is to evaluate the human tolerance and pharmacokinetics of LY030...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate the Effectiveness and Safety of LY03003 in Patients With Early Primary PD PHASE3 This study is to evaluate the effictiveness and safety of Ly03003 following...
Show More Location
Xuanwu Hospital Capital Medical University
Learn More & Join Trial
A Randomized, Open-Label, Crossover Study to Evaluate the Pharmacokinetic Profiles of Rotigotine After a Single Dose of LY03003 (28 mg) Versus After a Week of Daily NEUPRO® Transdermal Patch (4 mg Every 24 Hours) in Healthy Volunteers PHASE1 This is a randomized, open-label, 2-sequence, 2-treatment cross-over study ...
Show More Location
Pharmaceutical Research Associates, Inc.
Learn More & Join Trial
A Study to Evaluate the Pharmacokinetics and Safety of LY03003 in Patients With Advanced-stage PD PHASE1 This study is to evaluate the pharmacokinetics and safety of LY03003 in pat...
Show More Location
Xuanwu Hospital Capital Medical University
Learn More & Join Trial
A Clinical Trial to Evaluate the Pharmacodynamics/Pharmacokinetics and Safety of LY03003 in Early PD Patients PHASE1 A Clinical Trial to Evaluate the Pharmacodynamics/Pharmacokinetics and Safe...
Show More Location
Shengjing Hospital of China Medical University
Learn More & Join Trial